Contenido para descargar

¿Cuánto sabemos de biosimilares?

Novel Management and Screening Approaches for Haematological Complications of Gaucher’s disease

Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment

Scoring system to facilitate diagnosis of Gaucher disease

Gaucher Disease: New Expanded Classification Emphasizing Neurological Features

The Importance of a Multidisciplinary Approach in the Management of a Patient with Type I Gaucher disease

The road to biosimilars in rare diseases - ongoing lessonsfrom Gaucher disease

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments

A reappraisal of Gaucher disease-diagnosis and disease management algorithms

Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia

A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China

Gaucher disease and SARS-CoV-2 infection: Emerging management challenges

Understanding the natural history of Gaucher disease

Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry

The European Gaucher Alliance: a survey of member patient organisations’ activities, healthcare environments and concerns

Diagnosing Gaucher disease: an on-going need for increased awareness amongst haematologists

Treatment perspectives for the lysosomal storage diseases

Skeletal involvement in Gaucher disease: An observational multicenter study of prognostic factors in the Argentine Gaucher disease patients

The International Collaborative Gaucher Group GRAF (Gaucher Risk Assessment for Fracture) score: a composite risk score for assessing adult fracture risk in imiglucerase-treated Gaucher disease type 1 patients

Pregnancy outcome in women with Gaucher disease type 1 who had unplanned pregnancies during eliglustat clinical trials

Management of women with Gaucher disease in the reproductive age.

Gaucher disease and pregnancy

Hyperferritinemia and iron metabolism in Gaucher disease: Potential pathophysiological implications

Entrenamiento intensivo

Etiología genética


Generalidades y Diagnóstico temprano en pediatría

Enfermedad de Gaucher tipo 2

Enfermedad de Gaucher tipo 3

Algoritmo diagnóstico en adultos

Métodos de diagnóstico en el Laboratorio

Terapia de Reemplazo enzimático

Tratamiento durante el embarazo

Terapia de Reducción de Sustrato

Impacto óseo en EG

Imágenes de RX y RMN en EG

Rol de la densitometría en EG

Proyecto Óseo Argentino

Comorbilidades en EG

Comorbilidades_EG y Cáncer

Comorbilidades_EG y Parkinson

Diagnósticos poco pensados ante cuadros clínicos frecuentes: plaquetopenia y esplenomegalia en el paciente pediátrico

Enfermedades Lisosomales para pediatras (Generalidades)

Enfermedades Lisosomales para pediatras (Enfermedad de Gaucher)

Enfermedades Lisosomales para pediatras (Enfermedad de Niemman Pick, AMSD)